| Gene Tests May Boost Lung Cancer Care
SATURDAY, June 2 (HealthDay News) -- U.S. researchers say they've developed new tests that can determine the precise genetic pathways that lead to lung cancer. Being able to examine these genomic "signatures" may provide patients with alternatives to chemotherapy. For example, patients may be able to be treated with drugs that target the specific faulty pathway that caused their cancer, the researchers said. "Traditional chemotherapy is not always effective. Even when we are able to match the right chemotherapy with the right patient, 70 percent of patients with lung cancer may not respond to therapy. We need to take a different approach to those patients, and that is where these targeted therapies come in," lead investigator Dr. Anil Potti, an assistant professor of medicine at the Duke Institute for Genome Sciences and amp; Policy, said in a prepared statement.
Baptist Medical Center Creates New Web Page for Prostate Treatment ...
In an effort to educate men on their prostate cancer treatment options in Mississippi, Baptist created a new web page to explain the variety of treatments. (PRWEB) June 29, 2007 -- Baptist Cancer Services, a division of Baptist Medical Center in Jackson, Miss., has created a new web page to explain the different treatment options for prostate cancer. The new link is available on the cancer page of Baptist's website at www.mbhs.org then click the prostate cancer treatment link on the left side of the page. Through the years, Baptist Cancer Services, a division of Baptist Medical Center in Jackson, Miss., offers annual free prostate screenings every September and a variety of free educational seminars helping men understand their risk and treatment options. .
Prostate cancer treatment cuts hot flashes
ROCHESTER, Minn., June 4: A U.S. study finds use of low doses of an epileptic seizure medication can significantly reduce the occurrence of hot flashes in prostate cancer patients.The North Central Cancer Treatment Group researchers based at the Mayo Clinic found use of the drug gabapentin that's also used to treat nerve pain caused by shingles substantially reduces hot flashes in men undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.The investigators found gabapentin cut the frequency and intensity of hot flashes up to 46 percent in men receiving androgen deprivation therapy."To my knowledge, this is the first non-hormonal treatment of hot flashes in men, where results from a placebo-controlled trial are positive enough to support that a non-hormonal medication can be used to help some of our patients," lead investigator Dr.
|
